0001790340-24-000008.txt : 20240209 0001790340-24-000008.hdr.sgml : 20240209 20240209161246 ACCESSION NUMBER: 0001790340-24-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240208 FILED AS OF DATE: 20240209 DATE AS OF CHANGE: 20240209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hall Brett Matthew CENTRAL INDEX KEY: 0001870437 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40675 FILM NUMBER: 24615038 MAIL ADDRESS: STREET 1: C/O IMMUNEERING CORPORATION STREET 2: 245 MAIN STREET, SECOND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Immuneering Corp CENTRAL INDEX KEY: 0001790340 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 MAIN STREET, SECOND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-500-8080 MAIL ADDRESS: STREET 1: 245 MAIN STREET, SECOND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 wk-form4_1707513136.xml FORM 4 X0508 4 2024-02-08 0 0001790340 Immuneering Corp IMRX 0001870437 Hall Brett Matthew 245 MAIN STREET SECOND FLOOR CAMBRIDGE MA 02142 0 1 0 0 CHIEF SCIENTIFIC OFFICER 0 Stock Option 6.09 2024-02-08 4 A 0 130900 0 A 2034-02-08 Class A Common Stock 130900 130900 D The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2024, and will be fully vested and exercisable on January 1, 2028. /s/ Michael D. Bookman, Attorney-in-Fact for Brett M. Hall 2024-02-09